Relay Therapeutics, Inc. (RLAY) Tops Q2 EPS by 4c

Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q2 EPS of ($0.69), $0.04 better than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49